SCHEMBL23429176

SCHEMBL23429176

Cc1cccc(C(NC(C)CO)c2ccccc2)c1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 1/20 0.43
SLC6A5 Q9Y345 1/20 0.43
ACP3 P15309 1/20 0.43
EPHX1 P07099 1/20 0.42
TDP1 Q9NUW8 1/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
HSD17B2 P37059 1/20 0.39
GPR139 Q6DWJ6 1/20 0.39
MAPT P10636 2/20 0.38
ALOX12 P18054 2/20 0.38
HTT P42858 2/20 0.38
LMNA P02545 2/20 0.38
TRPA1 O75762 2/20 0.38
SLC6A2 P23975 2/20 0.37
SLC6A4 P31645 2/20 0.37
USP1 O94782 1/20 0.37
WDR48 Q8TAF3 1/20 0.37
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31067623 0.83 CPN1 (0.41) TDP1MEN1KMT2ALMNATRPA1
SCHEMBL18604835 0.83 CPN1 (0.41) TDP1MEN1KMT2ALMNATRPA1
SCHEMBL23428932 0.82 SLC6A9 (0.42) SLC6A9SLC6A5ACP3EPHX1TDP1
SCHEMBL23429020 0.82 ACP3 (0.45) SLC6A9SLC6A5ACP3EPHX1HSD17B2
SCHEMBL18604834 0.79 LDHB (0.41) TDP1MAPTLMNASLC6A4
SCHEMBL23429046 0.75 TDP1 (0.43) SLC6A9SLC6A5ACP3EPHX1TDP1
SCHEMBL25665915 0.74 ALDH1A1 (0.63) SLC6A9SLC6A5ACP3TDP1MEN1
SCHEMBL16131576 0.73 MEN1 (0.52) MEN1KMT2AALOX12HTTLMNA
SCHEMBL14252638 0.72 USP1 (0.44) ACP3EPHX1USP1WDR48
SCHEMBL4273016 0.72 SIGMAR1 (0.63) ACP3MEN1KMT2AMAPTALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4180424-A1 SUBSTITUTED PYRAZOLES AS HUMAN PLASMA KALLIKREIN INHIBITORS BioCryst Pharmaceuticals, Inc. (US) 2023-05-17 EP disclosed
EP-3828173-A1 SUBSTITUTED PYRAZOLES AS HUMAN PLASMA KALLIKREIN INHIBITORS BioCryst Pharmaceuticals, Inc. (US) 2021-06-02 EP disclosed